Georgetta Hatfield
Nurse Practitioner · Columbia, MONPI 1508084278
Payments from drug & device makers
Across 247 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Novartis$522
- UCB, Inc.$249
- Lilly USA, LLC$248
- Regeneron Healthcare Solutions, Inc.$209
- plus $906 from 17 others
What the payments were for
- Food & beverage$4,43593%
- Education$3267%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 104 | $1,609 |
| Johnson & Johnson | 40 | $1,018 |
| Novartis | 23 | $522 |
| UCB, Inc. | 11 | $249 |
| Lilly USA, LLC | 15 | $248 |
| Regeneron Healthcare Solutions, Inc. | 8 | $209 |
| E.r. Squibb & Sons, L.L.C. | 8 | $140 |
| Sanofi | 6 | $140 |
| Amgen | 6 | $117 |
| Pfizer | 6 | $113 |
| LEO Pharma Inc. | 5 | $94 |
| ANI Pharmaceuticals, Inc. | 3 | $71 |
| Incyte Corporation | 2 | $38 |
| Merz North America, Inc. | 1 | $23 |
| Kerecis Limited | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Organon | 1 | $21 |
| Botanix SB Inc | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$350
How this compares
$4,761 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 13 | $87,484 |
| Dupixent PenDupilumab | 12 | $43,263 |
| Clobetasol Propionate | 136 | $4,792 |
| Clindamycin Phosphate | 40 | $2,784 |
| Ketoconazole | 149 | $2,446 |
| Metronidazole | 31 | $1,923 |
| Tacrolimus | 14 | $1,841 |
| Minocycline Hcl | 47 | $1,586 |
| Desonide | 26 | $1,459 |
| Doxycycline Hyclate | 35 | $1,253 |
| Hydrocortisone | 74 | $947 |
| Triamcinolone Acetonide | 106 | $915 |
| ValacyclovirValacyclovir Hcl | 29 | $890 |
| Hydroxychloroquine Sulfate | 21 | $725 |
| Cyproheptadine Hcl | 17 | $548 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Columbia
- Janet SamuelsColumbia$19K
- Kwai Mung ChinColumbia$17K
- Jonathan BarnesColumbia$10K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.